BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 21763161)

  • 1. Chromosomal imbalances in successive moments of human bladder urothelial carcinoma.
    Nascimento e Pontes MG; da Silveira SM; Trindade Filho JC; Rogatto SR; Viana de Camargo JL
    Urol Oncol; 2013 Aug; 31(6):827-35. PubMed ID: 21763161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.
    Obermann EC; Junker K; Stoehr R; Dietmaier W; Zaak D; Schubert J; Hofstaedter F; Knuechel R; Hartmann A
    J Pathol; 2003 Jan; 199(1):50-7. PubMed ID: 12474226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.
    Montgomery EA; Shuster DD; Burkart AL; Esteban JM; Sgrignoli A; Elwood L; Vaughn DJ; Griffin CA; Epstein JI
    Am J Surg Pathol; 2006 Dec; 30(12):1502-12. PubMed ID: 17122505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
    Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
    Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular evidence supporting field effect in urothelial carcinogenesis.
    Jones TD; Wang M; Eble JN; MacLennan GT; Lopez-Beltran A; Zhang S; Cocco A; Cheng L
    Clin Cancer Res; 2005 Sep; 11(18):6512-9. PubMed ID: 16166427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
    Stoehr R; Zietz S; Burger M; Filbeck T; Denzinger S; Obermann EC; Hammerschmied C; Wieland WF; Knuechel R; Hartmann A
    Eur Urol; 2005 Jan; 47(1):58-63. PubMed ID: 15582250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of chromosome 17 and erbB-2 gene copy number in primary and metastatic bladder cancer.
    Sauter G; Moch H; Gasser TC; Mihatsch MJ; Waldman FM
    Cytometry; 1995 Sep; 21(1):40-6. PubMed ID: 8529469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization.
    Voorter C; Joos S; Bringuier PP; Vallinga M; Poddighe P; Schalken J; du Manoir S; Ramaekers F; Lichter P; Hopman A
    Am J Pathol; 1995 Jun; 146(6):1341-54. PubMed ID: 7778674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
    Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
    Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
    Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.
    Obermann EC; Meyer S; Hellge D; Zaak D; Filbeck T; Stoehr R; Hofstaedter F; Hartmann A; Knuechel R
    Oncol Rep; 2004 Apr; 11(4):745-51. PubMed ID: 15010867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic imbalances in urothelial cancer: intratumor heterogeneity versus multifocality.
    Prat E; Del Rey J; Camps J; Ponsa I; Lloreta J; Egozcue J; Gelabert A; Campillo M; Miro R
    Diagn Mol Pathol; 2008 Sep; 17(3):134-40. PubMed ID: 18382360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urothelium.
    Steidl C; Simon R; Bürger H; Brinkschmidt C; Hertle L; Böcker W; Terpe HJ
    J Pathol; 2002 Sep; 198(1):115-20. PubMed ID: 12210071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic modeling of human urinary bladder carcinogenesis.
    Czerniak B; Li L; Chaturvedi V; Ro JY; Johnston DA; Hodges S; Benedict WF
    Genes Chromosomes Cancer; 2000 Apr; 27(4):392-402. PubMed ID: 10719370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma.
    Hartmann A; Moser K; Kriegmair M; Hofstetter A; Hofstaedter F; Knuechel R
    Am J Pathol; 1999 Mar; 154(3):721-7. PubMed ID: 10079249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cytogenetic characterization and diagnostics of bladder cancer.
    Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
    Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular changes in development and progression of urothelial carcinoma].
    Hartmann A
    Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.